Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Classement en actions #27739
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Prix de l'action
$2.14
Capitalisation boursière
$30.63M
Changement (1 jour)
0.16%
Changement (1 an)
-62.09%
Pays
KR
Échange IMBdx (461030)

Catégorie

Ratio P/B pour IMBdx (461030)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de IMBdx, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour IMBdx de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH